MedTrace Logo

Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging

NCT02400840 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-05-26

No results posted yet for this study

Summary

Acute heart allograft rejection is a common complication after orthotopic heart transplantation. Primary objective of this study is to assess cardiac MRI as a tool for acute heart graft rejection screening, by detecting changes in myocardium structure especially extracellular volume.

Conditions

  • Cardiac Graft

Interventions

PROCEDURE

cardiac MRI

Cardiac MRI is done using gadobenic acid intravenous injection 0.2 ml/kg one time

DRUG

gadobenic acid intravenous injection 0.2 ml/kg

gadobenic acid intravenous injection 0.2 ml/kg is used one time for cardiac MRI assessment

Sponsors & Collaborators

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • Arnaud GAY, MD · University Hospital, Rouen

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-01-31
Completion
2018-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02400840 on ClinicalTrials.gov